Safety Alerts & Recalls

What does this mean?

This recall for Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you take Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg and are concerned, you should speak to your doctor.

Forest Pharmaceuticals Inc. Recalls Several Lots of Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg

Forest Pharmaceuticals Inc. has recalled several lots of Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg. The following lot numbers have been recalled because these lots failed the manufacturer routine tests that measure the tablets’ ability to dissolve: 1069783, 1079546, 1082538, 1071614, 1072823, 1077653, 1078959, 1073308.

Campral contains the active ingredient acamprosate calcium and is commonly used to help people with alcohol dependence to quit alcohol. This recall alert only applies to the select lots of Campral (acamprosate calcium) Delayed-Release Tablets, 333 mg. No other acamprosate calcium products were involved in this recall.

To view the FDA notice about this recall, please visit: more information here

Source: FDA
Publication Date: 2012-05-15
Last Updated: 2012-05-15

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.
Back to Consumer Med Safety